Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RX-3117 + Abraxane in Metastatic Pancreatic Cancer
NCT03189914Phase 2Completed
- Sponsor
- Processa Pharmaceuticals, Inc.
- Start
- Oct 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roducitabine, sponsored by Processa Pharmaceuticals, Inc.. Started Oct 2017; status: completed.
02
Drugs
roducitabine
Beyond the preview
Go deeper on NCT03189914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189914.